{"id":216500,"date":"2025-06-24T10:03:29","date_gmt":"2025-06-24T15:03:29","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/06\/nuvalent-announces-timing-of-pivotal-data-for-tki-pre-treated-patients-with-advanced-ros1-positive-nsclc-from-arros-1-clinical-trial-of-zidesamtinib"},"modified":"2025-06-24T10:03:29","modified_gmt":"2025-06-24T15:03:29","slug":"nuvalent-announces-timing-of-pivotal-data-for-tki-pre-treated-patients-with-advanced-ros1-positive-nsclc-from-arros-1-clinical-trial-of-zidesamtinib","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/06\/nuvalent-announces-timing-of-pivotal-data-for-tki-pre-treated-patients-with-advanced-ros1-positive-nsclc-from-arros-1-clinical-trial-of-zidesamtinib","title":{"rendered":"Nuvalent Announces Timing of Pivotal Data for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC from ARROS-1 Clinical Trial of Zidesamtinib"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/nuvalent-announces-timing-of-pivotal-data-for-tki-pre-treated-patients-with-advanced-ros1-positive-nsclc-from-arros-1-clinical-trial-of-zidesamtinib3.jpg\"><\/a><\/p>\n<p>\/PRNewswire\/ \u2014 Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically\u2026<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\/PRNewswire\/ \u2014 Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically\u2026<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-216500","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/216500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=216500"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/216500\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=216500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=216500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=216500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}